1539. A Nine-Gene Blood-Based Signature Meets the World Health Organization Target Product Profiles for Diagnosis of Active Tuberculosis and Predicting Progression from Latent to Active Disease

BACKGROUND: As part of its End TB strategy, the WHO has identified the need for non-sputum-based diagnostics that meet target product profiles (TPP) of 90% sensitivity and 70% specificity for diagnosis of Active TB (ATB) and 75% sensitivity and specificity for predicting progression from Latent TB (...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Sanjana, Rao, Aditya, Scott, Madeleine, Crudu, Valeriu, Rodwell, Timothy, Catanzaro, Donald, Catanzaro, Antonino, Khatri, Purvesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752284/
http://dx.doi.org/10.1093/ofid/ofac492.094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752284/
http://dx.doi.org/10.1093/ofid/ofac492.094

Ejemplares similares